Market Segmentation:
- By Product Type
- Hormonal Therapy
- Non-Hormonal Therapy
- Combination Therapy
- Others (Dietary Supplements, Herbal Remedies)
- By Route of Administration
- Oral
- Transdermal
- Vaginal
- Parenteral
- Others (Nasal, Suppositories)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others (Clinics, Specialty Pharmacies)
- By Treatment Type
- Vasomotor Symptoms
- Vaginal Atrophy
- Osteoporosis
- Others (Sleep Disturbances, Mood Changes)
- By End-User
- Hospitals
- Gynecology Clinics
- Homecare Settings
- Others (Ambulatory Surgical Centers, Specialty Clinics)
- By Therapy
- Estrogen Therapy
- Progestin Therapy
- Combined Hormone Therapy
- Selective Estrogen Receptor Modulators (SERMs)
- Others (Tissue-Selective Estrogen Complex, Phytoestrogens)
- By Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Menopause industry is US$ 14.2 billion.
Increasing aging female population globally, Rising awareness about menopause, Growing demand for effective treatments, Supportive government initiatives, Increasing research and development activities, Advances in diagnostic techniques, Availability of novel therapies, Improving healthcare infrastructure, Increasing disposable income, Expansion of healthcare coverage.
Risks associated with hormone replacement therapy, High cost of treatments, Lack of awareness in developing regions, Stigma and misconceptions surrounding menopause, Stringent regulatory requirements, Limited reimbursement policies, Preference for alternative therapies.
The leading component segment in the Menopause Market is the Hormonal Therapy segment, used to alleviate menopausal symptoms.
Pfizer Inc., Novartis AG, Merck & Co., Inc., Bayer AG, Allergan plc, Novo Nordisk A/S, Eli Lilly and Company, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd.
The North America region is expected to lead the Menopause Market with a market share of 38.2% in 2023.
Aging female population globally, Rising awareness about menopause, Growing demand for effective treatments, Supportive government initiatives, Increasing research and development activities, Advances in diagnostic techniques, Availability of novel therapies, Improving healthcare infrastructure.